Bio-Techne

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases.

CEO

Kim Kelderman

CEOKim Kelderman

Employees

3,100

Employees3,100

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

1976

Founded1976

Employees

3,100

Employees3,100

TECH Key Statistics

Market cap

8.48B

Market cap8.48B

Price-Earnings ratio

60.87

Price-Earnings ratio60.87

Dividend yield

0.64%

Dividend yield0.64%

Average volume

2.37M

Average volume2.37M

High today

$54.40

High today$54.40

Low today

$51.00

Low today$51.00

Open price

$51.75

Open price$51.75

Volume

1.51M

Volume1.51M

52 Week high

$85.57

52 Week high$85.57

52 Week low

$46.01

52 Week low$46.01

TECH News

Simply Wall St 4d

Bio-Techne Third Quarter 2025 Earnings: EPS Misses Expectations

Advertisement Bio-Techne ( ) Third Quarter 2025 Results Key Financial Results Revenue: US$316.2m (up 4.2% from 3Q 2024). Net income: US$22.6m (down 54% from...

TipRanks 5d

Bio-Techne reports Q3 adjusted EPS 56c, consensus 51c

Reports Q3 revenue $316.18M, consensus $317.33M. “Despite a dynamic macroenvironment, the Bio-Techne (TECH) team once again executed at a high level and deliver...

Analyst ratings

67%

of 18 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.